Sachin Kamal-Bahl

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review
    Sachin Kamal-Bahl
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 506 W Fayette St, Suite 113, Baltimore, MD 21201
    Arch Pediatr Adolesc Med 156:1034-41. 2002
  2. ncbi Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries
    Sachin J Kamal-Bahl
    University of Maryland Baltimore, School of Pharmacy, Maryland 21201, USA
    J Am Geriatr Soc 51:1099-104. 2003
  3. ncbi National trends in and predictors of propoxyphene use in community-dwelling older adults
    Sachin Kamal-Bahl
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, Maryland, USA
    Am J Geriatr Pharmacother 3:186-95. 2005
  4. ncbi Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999
    Bruce Stuart
    School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Am J Geriatr Pharmacother 1:61-74. 2003
  5. ncbi The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients
    Kathleen A Foley
    Outcomes Research and Econometrics, Medstat, Inc, New Hope, Pennsylvania, USA
    Med Care 44:421-8. 2006

Collaborators

Detail Information

Publications5

  1. ncbi Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review
    Sachin Kamal-Bahl
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 506 W Fayette St, Suite 113, Baltimore, MD 21201
    Arch Pediatr Adolesc Med 156:1034-41. 2002
    ..To systematically review all published economic analyses of the only 2 available agents for respiratory syncytial virus immunoprophylaxis in high-risk infants: respiratory syncytial virus immunoglobulin intravenous and palivizumab...
  2. ncbi Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries
    Sachin J Kamal-Bahl
    University of Maryland Baltimore, School of Pharmacy, Maryland 21201, USA
    J Am Geriatr Soc 51:1099-104. 2003
    ....
  3. ncbi National trends in and predictors of propoxyphene use in community-dwelling older adults
    Sachin Kamal-Bahl
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, Maryland, USA
    Am J Geriatr Pharmacother 3:186-95. 2005
    ..Several pain management guidelines and explicit medication-use criteria identify propoxyphene as an inappropriate medication for use in older adults...
  4. ncbi Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999
    Bruce Stuart
    School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Am J Geriatr Pharmacother 1:61-74. 2003
    ..However, it is not known whether the Beers criteria have had a beneficial effect on prescribing practices...
  5. ncbi The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients
    Kathleen A Foley
    Outcomes Research and Econometrics, Medstat, Inc, New Hope, Pennsylvania, USA
    Med Care 44:421-8. 2006
    ....